119 related articles for article (PubMed ID: 29528587)
1. CD81 and CD19 as Marker of Activity in Systemic Lupus Erythematosus Disease.
Abu-Zahab Z; Gad NM; Sabry S; Nassib SA
Egypt J Immunol; 2017 Jun; 24(2):141-149. PubMed ID: 29528587
[TBL] [Abstract][Full Text] [Related]
2. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
Bijl M; Horst G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
[TBL] [Abstract][Full Text] [Related]
3. CD19/22 balance relates to improvement of disease activity in systemic lupus erythematosus.
Suzuki J; Nakano S; Nakairi Y; Mitsuo A; Amano H; Morimoto S; Tokano Y; Takasaki Y
Mod Rheumatol; 2006; 16(4):235-8. PubMed ID: 16906374
[TBL] [Abstract][Full Text] [Related]
4. CD38, CD81 and BAFFR combined expression by transitional B cells distinguishes active from inactive systemic lupus erythematosus.
Henriques A; Silva I; Inês L; Souto-Carneiro MM; Pais ML; Trindade H; da Silva JA; Paiva A
Clin Exp Med; 2016 May; 16(2):227-32. PubMed ID: 25894569
[TBL] [Abstract][Full Text] [Related]
5. Patients with systemic lupus erythematosus show increased proportions of CD19
Zhu Q; Li Y; Zhang L; Wang M; Chen Z; Shi J; Li J; Li B; Li Z; Wang Y; Xie C
Clin Rheumatol; 2021 Jan; 40(1):151-165. PubMed ID: 32542581
[TBL] [Abstract][Full Text] [Related]
6. The potential role of Ets-1 and miR-326 in CD19
Jin L; Fang X; Dai C; Xiang N; Tao J; Sun X; Azmi F; Cao Q; Li X; Wang Y; Li X
Clin Rheumatol; 2019 Apr; 38(4):1031-1038. PubMed ID: 30456527
[TBL] [Abstract][Full Text] [Related]
7. CD19
Xiong H; Tang Z; Xu Y; Shi Z; Guo Z; Liu X; Tan G; Ai X; Guo Q
Adv Rheumatol; 2022 Dec; 62(1):48. PubMed ID: 36494762
[TBL] [Abstract][Full Text] [Related]
8. Elevated CD19
Ju B; Wang J; Mo L; Huang J; Hao Z; Lv X; Pu D; He L
Int Immunopharmacol; 2022 Jan; 102():108403. PubMed ID: 34857478
[TBL] [Abstract][Full Text] [Related]
9. The role and clinical significance of programmed cell death- ligand 1 expressed on CD19
Jia XY; Zhu QQ; Wang YY; Lu Y; Li ZJ; Li BQ; Tang J; Wang HT; Song CW; Xie CH; Chen LJ
Clin Immunol; 2019 Jan; 198():89-99. PubMed ID: 30502542
[TBL] [Abstract][Full Text] [Related]
10. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
Iwata S; Yamaoka K; Niiro H; Jabbarzadeh-Tabrizi S; Wang SP; Kondo M; Yoshikawa M; Akashi K; Tanaka Y
Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781
[TBL] [Abstract][Full Text] [Related]
11. Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia.
García-Valladares I; Atisha-Fregoso Y; Richaud-Patin Y; Jakez-Ocampo J; Soto-Vega E; Elías-López D; Carrillo-Maravilla E; Cabiedes J; Ruiz-Argüelles A; Llorente L
Lupus; 2006; 15(9):600-5. PubMed ID: 17080916
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.
Li J; An L; Zhang Z
Clin Exp Rheumatol; 2014; 32(1):48-53. PubMed ID: 23981509
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
[TBL] [Abstract][Full Text] [Related]
14. The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytes.
Vences-Catalán F; Rajapaksa R; Levy S; Santos-Argumedo L
Immunology; 2012 Sep; 137(1):48-55. PubMed ID: 22564057
[TBL] [Abstract][Full Text] [Related]
15. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus.
Jacobi AM; Odendahl M; Reiter K; Bruns A; Burmester GR; Radbruch A; Valet G; Lipsky PE; Dörner T
Arthritis Rheum; 2003 May; 48(5):1332-42. PubMed ID: 12746906
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD19+CD24highCD38high B cells, IL‑10 and IL‑10R in peripheral blood from patients with systemic lupus erythematosus.
Wang T; Li Z; Li X; Chen L; Zhao H; Jiang C; Song L
Mol Med Rep; 2017 Nov; 16(5):6326-6333. PubMed ID: 28901380
[TBL] [Abstract][Full Text] [Related]
18. The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment.
Shoham T; Rajapaksa R; Boucheix C; Rubinstein E; Poe JC; Tedder TF; Levy S
J Immunol; 2003 Oct; 171(8):4062-72. PubMed ID: 14530327
[TBL] [Abstract][Full Text] [Related]
19. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
[TBL] [Abstract][Full Text] [Related]
20. Peripheral B cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: decreased memory B cells and membrane CD19 expression.
Korganow AS; Knapp AM; Nehme-Schuster H; Soulas-Sprauel P; Poindron V; Pasquali JL; Martin T
J Autoimmun; 2010 Jun; 34(4):426-34. PubMed ID: 19963348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
